Natural sesquiterpene lactones in prostate cancer therapy: mechanisms and sources
- PMID: 40372575
- DOI: 10.1007/s12032-025-02740-2
Natural sesquiterpene lactones in prostate cancer therapy: mechanisms and sources
Abstract
Prostate cancer is a condition characterized by the uncontrolled proliferation of abnormal cells inside the prostate gland, part of the male reproductive system. Prostate cancer is the most common cancer among men and the second largest cause of cancer-related mortality in the United States. A novel approach to treating advanced Prostate cancer has emerged, attributable to the enhanced effectiveness of new pharmacological agents sourced from natural origins and this has led to increased rates of global existence and progression-free survival. Sesquiterpene lactones and their derivatives are now used worldwide to create and manufacture innovative cancer therapeutics. A thorough search was performed according to PRISMA guidelines in SciMed, PubMed, and Google Scholar, focusing on publications published from 1999 to 2024. The safety, efficacy, and bioactivity of sesquiterpene lactones must be evaluated via clinical trials, in vitro studies, and in vivo research and data was rigorously gathered and validated to verify its accuracy and usefulness. Prostate cancer may be treated far more effectively using naturally occurring sesquiterpene lactone molecules. The most prominent sesquiterpene lactones identified were artemisinin, alantolactone, costunolide, helenalin, cynaropicrin, parthenolide, and inuviscolide, which are originated from botanical sources like Ferula penninervis, Tanacetum argenteum, Artemisia kopetdaghensis, Cichorium intybus, Carpesium divaricatum, and Leptocarpha rivularis. Numerous studies indicated that sesquiterpene lactones may treat cancer by modifying many cellular signaling pathways, including PI3K/AKT, MAPK, JNK, NF-κB, TNF-α, and STAT3. Sesquiterpene lactones were shown to be significant in suppressing the proliferation of prostate cancer cell lines (DU-145, PC-3, LNCaP, MR49F, and BPH-1) in both laboratory and clinical settings.
Keywords: MAPK; NF-κβ; Natural products; Prostate cancer; STAT3; Sesquiterpene lactone.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no conflicts of interest related to this study.
Similar articles
-
Sesquiterpene lactones from Cichorium intybus exhibit potent anti-inflammatory and hepatoprotective effects by repression of NF-κB and enhancement of NRF2.J Ethnopharmacol. 2025 Mar 13;343:119439. doi: 10.1016/j.jep.2025.119439. Epub 2025 Feb 2. J Ethnopharmacol. 2025. PMID: 39904423
-
Liquid-Liquid Chromatography Separation of Guaiane-Type Sesquiterpene Lactones from Ferula penninervis Regel & Schmalh. and Evaluation of Their In Vitro Cytotoxic and Melanin Inhibitory Potential.Int J Mol Sci. 2021 Oct 3;22(19):10717. doi: 10.3390/ijms221910717. Int J Mol Sci. 2021. PMID: 34639057 Free PMC article.
-
Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.Curr Med Chem. 2016;23(23):2397-420. doi: 10.2174/0929867323666160510123255. Curr Med Chem. 2016. PMID: 27160533 Free PMC article. Review.
-
Isodeoxyelephantopin, a Sesquiterpene Lactone Induces ROS Generation, Suppresses NF-κB Activation, Modulates LncRNA Expression and Exhibit Activities Against Breast Cancer.Sci Rep. 2019 Nov 29;9(1):17980. doi: 10.1038/s41598-019-52971-3. Sci Rep. 2019. PMID: 31784542 Free PMC article.
-
What made sesquiterpene lactones reach cancer clinical trials?Drug Discov Today. 2010 Aug;15(15-16):668-78. doi: 10.1016/j.drudis.2010.06.002. Epub 2010 Jun 9. Drug Discov Today. 2010. PMID: 20541036 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous